Eli Lilly EPS - Earnings per Share 2006-2018 | LLY

Eli Lilly annual and quarterly earnings per share history from 2006 to 2018. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Eli Lilly EPS for the quarter ending December 31, 2018 was $1.10, a 170.06% decline year-over-year.
  • Eli Lilly EPS for the twelve months ending December 31, 2018 was $3.13, a 1747.37% decline year-over-year.
  • Eli Lilly 2018 annual EPS was $3.13, a 1747.37% decline from 2017.
  • Eli Lilly 2017 annual EPS was $-0.19, a 107.36% decline from 2016.
  • Eli Lilly 2016 annual EPS was $2.58, a 14.16% increase from 2015.
Eli Lilly Annual EPS
2018 $3.13
2017 $-0.19
2016 $2.58
2015 $2.26
2014 $2.23
2013 $4.32
2012 $3.66
2011 $3.90
2010 $4.58
2009 $3.94
2008 $-1.89
2007 $2.71
2006 $2.45
2005 $1.81
Eli Lilly Quarterly EPS
Q4 2018 $1.10
Q3 2018 $1.12
Q2 2018 $-0.25
Q1 2018 $1.16
Q4 2017 $-1.57
Q3 2017 $0.53
Q2 2017 $0.95
Q1 2017 $-0.10
Q4 2016 $0.73
Q3 2016 $0.73
Q2 2016 $0.71
Q1 2016 $0.41
Q4 2015 $0.45
Q3 2015 $0.75
Q2 2015 $0.56
Q1 2015 $0.50
Q4 2014 $0.40
Q3 2014 $0.47
Q2 2014 $0.68
Q1 2014 $0.68
Q4 2013 $0.68
Q3 2013 $1.11
Q2 2013 $1.11
Q1 2013 $1.42
Q4 2012 $0.74
Q3 2012 $1.18
Q2 2012 $0.83
Q1 2012 $0.91
Q4 2011 $0.77
Q3 2011 $1.11
Q2 2011 $1.07
Q1 2011 $0.95
Q4 2010 $1.05
Q3 2010 $1.18
Q2 2010 $1.22
Q1 2010 $1.13
Q4 2009 $0.82
Q3 2009 $0.86
Q2 2009 $1.06
Q1 2009 $1.20
Q4 2008 $-3.31
Q3 2008 $-0.43
Q2 2008 $0.88
Q1 2008 $0.97
Q4 2007 $0.78
Q3 2007 $0.85
Q2 2007 $0.61
Q1 2007 $0.47
Q4 2006 $0.12
Q3 2006 $0.80
Q2 2006 $0.76
Q1 2006 $0.77
Q4 2005 $0.63
Q3 2005 $0.73
Q2 2005 $-0.23
Q1 2005 $0.68
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $119.326B $24.556B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $368.953B 16.73
Pfizer (PFE) United States $234.424B 13.13
Merck (MRK) United States $197.334B 16.86
Novartis AG (NVS) Switzerland $176.507B 15.01
Novo Nordisk (NVO) Denmark $118.242B 19.13
AbbVie (ABBV) United States $114.422B 9.81
Sanofi (SNY) France $103.609B 12.79
GlaxoSmithKline (GSK) United Kingdom $98.852B 12.98
AstraZeneca (AZN) United Kingdom $98.276B 11.21
Bristol-Myers Squibb (BMY) United States $74.378B 11.44